Litcius/Paper detail

Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis

Anubodh S. Varshney, David E. Wang, Ankeet S. Bhatt, Alexander Blood, Musa Sharkawi, Hasan K. Siddiqi, Muthiah Vaduganathan, Peter Monteleone, Manesh R. Patel, W. Schuyler Jones, Renato D. Lópes, Mandeep R. Mehra, Deepak L. Bhatt, Ajar Kochar

2020American Heart Journal18 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicineClinical trialHydroxychloroquineRandomized controlled trialCoronavirus disease 2019 (COVID-19)DiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Pharmacological Receptor Mechanisms and Effects
Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis | Litcius